A Novel Two-step Pathway to Detect Liver Cirrhosis Earlier

Dr. Ankur Srivastava
Consultant Gastroenterologist and Hepatologist
Southmead Hospital, North Bristol Trust

Nonalcoholic fatty liver disease (NAFLD) affects 20%-30% of the global population and can lead to more severe conditions including advanced fibrosis and cirrhosis. In this video, Dr. Ankur Srivastava, Consultant Gastroenterologist and Hepatologist at Southmead Hospital, North Bristol Trust, discusses his two-step primary care pathway approach of utilizing non-invasive tests to reduce unnecessary referrals and improve detection of severe disease in patients with NAFLD. This work was recently published in the Journal of Hepatology in August 2019.